Overview

A Multicenter, Open Label Trial To Evaluate Pain Relief With Intravenous Followed By Oral Therapy With Parecoxib/Valdecoxib 40 Mg/Day For Treatment Of Post-Laparoscopic Surgery Pain

Status:
Terminated
Trial end date:
2004-07-01
Target enrollment:
Participant gender:
Summary
The objectives of this study were to assess the analgesic efficacy and safety of parecoxib/valdecoxib on post-laparoscopic surgery analgesia.
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer
Treatments:
Parecoxib
Valdecoxib